407 related articles for article (PubMed ID: 27699633)
1. Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.
Liu J; Yang B; Ke J; Li W; Suen WC
Drugs Aging; 2016 Oct; 33(10):685-697. PubMed ID: 27699633
[TBL] [Abstract][Full Text] [Related]
2. Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment.
Montoliu-Gaya L; Villegas S
Expert Rev Mol Med; 2016 Jun; 18():e13. PubMed ID: 27357999
[TBL] [Abstract][Full Text] [Related]
3. Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise.
van Dyck CH
Biol Psychiatry; 2018 Feb; 83(4):311-319. PubMed ID: 28967385
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
5. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives.
Schilling S; Rahfeld JU; Lues I; Lemere CA
Molecules; 2018 May; 23(5):. PubMed ID: 29751505
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.
Cehlar O; Skrabana R; Revajova V; Novak M
Bratisl Lek Listy; 2018; 119(4):201-204. PubMed ID: 29663816
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
9. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
10. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
Murakami K
Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
[TBL] [Abstract][Full Text] [Related]
11. Critical Appraisal of Amyloid Lowering Agents in AD.
Decourt B; Boumelhem F; Pope ED; Shi J; Mari Z; Sabbagh MN
Curr Neurol Neurosci Rep; 2021 Jun; 21(8):39. PubMed ID: 34110536
[TBL] [Abstract][Full Text] [Related]
12. A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
Demattos RB; Lu J; Tang Y; Racke MM; Delong CA; Tzaferis JA; Hole JT; Forster BM; McDonnell PC; Liu F; Kinley RD; Jordan WH; Hutton ML
Neuron; 2012 Dec; 76(5):908-20. PubMed ID: 23217740
[TBL] [Abstract][Full Text] [Related]
13. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
14. Alternative Abeta immunotherapy approaches for Alzheimer's disease.
Town T
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):114-27. PubMed ID: 19355932
[TBL] [Abstract][Full Text] [Related]
15. Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy.
Nitsch RM; Hock C
Neurotherapeutics; 2008 Jul; 5(3):415-20. PubMed ID: 18625453
[TBL] [Abstract][Full Text] [Related]
16. A Rational Structured Epitope Defines a Distinct Subclass of Toxic Amyloid-beta Oligomers.
Silverman JM; Gibbs E; Peng X; Martens KM; Balducci C; Wang J; Yousefi M; Cowan CM; Lamour G; Louadi S; Ban Y; Robert J; Stukas S; Forloni G; Hsiung GR; Plotkin SS; Wellington CL; Cashman NR
ACS Chem Neurosci; 2018 Jul; 9(7):1591-1606. PubMed ID: 29614860
[TBL] [Abstract][Full Text] [Related]
17. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
Rygiel K
Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
[TBL] [Abstract][Full Text] [Related]
18. Passive Immunotherapies Targeting Amyloid-
Marković M; Milošević J; Wang W; Cao Y
Mol Pharmacol; 2023 Dec; 105(1):1-13. PubMed ID: 37907353
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy against amyloid pathology in Alzheimer's disease.
Galimberti D; Ghezzi L; Scarpini E
J Neurol Sci; 2013 Oct; 333(1-2):50-4. PubMed ID: 23299047
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β immunotherapy reduces amyloid plaques and astroglial reaction in aged domestic dogs.
Neus Bosch M; Pugliese M; Andrade C; Gimeno-Bayón J; Mahy N; Rodriguez MJ
Neurodegener Dis; 2015; 15(1):24-37. PubMed ID: 25531153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
